Trials / Conditions / Malignant Digestive System Neoplasm

Malignant Digestive System Neoplasm

22 registered clinical trials studyying Malignant Digestive System Neoplasm — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastroint NCT07456852	Mayo Clinic	Phase 1 / Phase 2
Recruiting	Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays NCT07283939	Alliance for Clinical Trials in Oncology	N/A
Recruiting	Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study NCT07215624	Wake Forest University Health Sciences	—
Recruiting	Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer NCT06855524	Mayo Clinic	Phase 2
Completed	Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers NCT06374251	University of Southern California	N/A
Completed	GCC Agonist Signal in the Small Intestine NCT05107219	University of Wisconsin, Madison	Phase 1
Completed	Remote Monitoring in Cancer Care: A Platform Study NCT05018208	Mayo Clinic	—
Active Not Recruiting	Perioperative Telemonitoring to Optimize Cancer Care and Outcomes NCT04986566	City of Hope Medical Center	N/A
Completed	Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced NCT04505553	University of Washington	Phase 2
Active Not Recruiting	A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma NCT04111172	Thomas Jefferson University	Phase 2
Completed	Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913	City of Hope Medical Center	—
Recruiting	Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers NCT04629677	M.D. Anderson Cancer Center	—
Recruiting	2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers NCT03800693	Emory University	Phase 2
Withdrawn	Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, NCT03563352	University of Southern California	—
Completed	Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal C NCT03267524	City of Hope Medical Center	N/A
Recruiting	Molecular Epidemiology of Biliary Tree Cancers NCT05179486	M.D. Anderson Cancer Center	—
Active Not Recruiting	Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Co NCT02713269	M.D. Anderson Cancer Center	Phase 2
Completed	Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors NCT02319018	National Cancer Institute (NCI)	Phase 1
Completed	Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors NCT02192333	Fred Hutchinson Cancer Center	N/A
Active Not Recruiting	Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Br NCT02221700	M.D. Anderson Cancer Center	N/A
Terminated	Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients NCT02550119	University of Southern California	N/A
Recruiting	Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy NCT00991094	M.D. Anderson Cancer Center	—